UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 174

Sortiert nach

Impact of patatin‐like phospholipase domain containing 3 rs738409 G/G genotype on hepatic decompensation and mortality in patients with portal hypertension

Alimentary pharmacology & therapeutics, 2018-08, Vol.48 (4), p.451-459

2018

Volltextzugriff (PDF)

Exclusion of Varices Via Transient Elastography Combined with Platelet Count According to the Baveno VI Guidelines can Only be Made for Large not Small Varices

Journal of hepatology, 2016, Vol.64 (2), p.S283-S283

2016

Volltextzugriff (PDF)

The Albicc Model: A new Prognostic Tool for Prediction of Short-Term Survival in Patients with End-Stage Liver Disease

Journal of hepatology, 2016, Vol.64 (2), p.S284-S284

2016

Volltextzugriff (PDF)

Bacterial infections in cirrhosis – a retrospective analysis updating on microbiology and resistance rates

Journal of hepatology, 2017, Vol.66 (1), p.S577-S577

2017

Volltextzugriff (PDF)

P1027 IS THE ELF-SCORE A VALID SUBSTITUTION FOR HVPG TO DETECT CLINICALLY SIGNIFICANT PORTAL HYPERTENSION (CSPH) NON-INVASIVELY?

Journal of hepatology, 2014-04, Vol.60 (1), p.S417-S417

2014

Volltextzugriff (PDF)

P524 COMPARISON OF DIFFERENT MODELS IN PREDICTING CLINICALLY SIGNIFICANT PORTAL HYPERTENSION INCLUDING ELF-SCORE AND vWF-Ag

Journal of hepatology, 2014-04, Vol.60 (1), p.S244-S245

2014

Volltextzugriff (PDF)

P0130 : VITRO-Score (vWF-Ag/thrombocytes) predicts mortality in patients with liver cirrhosis independent of child-pugh stage and meld score

Journal of hepatology, 2015-04, Vol.62, p.S349-S350

2015

Volltextzugriff (PDF)

Liver Stiffness Assessed by Transient Elastography can not Predict the Hemodynamic Response to Non-Selective Betablockers

Journal of hepatology, 2016, Vol.64 (2), p.S287-S288

2016

Volltextzugriff (PDF)

Von Willebrand factor antigen predicts portal hypertensive bleeding, infections, and survival, independently of portal hypertension severity

Journal of hepatology, 2017, Vol.66 (1), p.S373-S374

2017

Volltextzugriff (PDF)

The novel point shear-wave elastography method ElastPQ® is accurate for non-invasive evaluation of liver fibrosis and portal hypertension

Journal of hepatology, 2017, Vol.66 (1), p.S674-S674

2017

Volltextzugriff (PDF)

Preoperative von willebrand factor – antigen predicts clinical outcome after liver resection: a prospective, international, multicenter trial

Journal of hepatology, 2017, Vol.66 (1), p.S194-S194

2017

Volltextzugriff (PDF)

239 INFLUENCE OF BMI ON THE RESPONSE TO BETA-BLOCKER THERAPY IN PRIMARY AND SECONDARY PROPHYLAXIS OF VARICEAL BLEEDING IN LIVER CIRRHOSIS

Journal of hepatology, 2013-04, Vol.58, p.S103-S103

2013

Volltextzugriff (PDF)

P1083 VON WILLEBRAND FACTOR ANTIGEN (vWF-Ag): A NON-INVASIVE PREDICTOR OF TREATMENT RESPONSE AND SEVERE ADVERSE EVENTS IN HCV PATIENTS WITH DAA BASED TRIPLE THERAPY

Journal of hepatology, 2014-04, Vol.60 (1), p.S438-S438

2014

Volltextzugriff (PDF)

P0218 : Factors associated with hemodynamic response to propranolol and carvedilol in cirrhotic patients

Journal of hepatology, 2015-04, Vol.62, p.S388-S388

2015

Volltextzugriff (PDF)

O019 : The value of different non-invasive tests for predicting the presence of clinically significant portal hypertension and esophageal varices in cirrhotic patients

Journal of hepatology, 2015-04, Vol.62, p.S200-S200

2015

Volltextzugriff (PDF)

P0212 : Identifying the trigger matters – outcome of severe acute kidney injury in patients with cirrhosis and ascites

Journal of hepatology, 2015-04, Vol.62, p.S385-S385

2015

Volltextzugriff (PDF)

P0208 : Hemodynamic response to non-selective beta-blockers is not influenced by the presence of metabolic syndrome

Journal of hepatology, 2015-04, Vol.62, p.S383-S384

2015

Volltextzugriff (PDF)

O050 : A new algorithm for predicting the hepatocellular carcinoma occurrence in cirrhotic patients

Journal of hepatology, 2015-04, Vol.62, p.S216-S217

2015

Volltextzugriff (PDF)

Interferon-Free Daa Regimens Decrease Portal Pressure and Halt Histological Necroinflammation in HIV/HCV coinfected Patients

Journal of hepatology, 2016, Vol.64 (2), p.S623-S623

2016

Volltextzugriff (PDF)

The Evolution of Portal Pressure after Viral Suppression with Interferon-Free Therapies and its Correlation with the Change in Liver Stiffness

Journal of hepatology, 2016, Vol.64 (2), p.S138-S138

2016

Volltextzugriff (PDF)

621 EVALUATION OF A NEW BALLOON OCCLUSION CATHETER DESIGNED FOR HVPG MEASUREMENT

Journal of hepatology, 2012-04, Vol.56, p.S246-S246

2012

Volltextzugriff (PDF)

1410 A RANDOMIZED, CONTROLLED, MULTICENTRE TRIAL COMPARING ENDOSCOPIC BAND LIGATION VERSUS TIPS IN CIRRHOTIC PATIENTS WITH RECURRENT VARICEAL BLEEDING NON-RESPONDING TO PHARMACOLOGICAL THERAPY

Journal of hepatology, 2012-04, Vol.56, p.S555-S555

2012

Volltextzugriff (PDF)

202 VON WILLEBRAND FACTOR – A MARKER FOR HEPATOPULMONARY SYNDROME

Journal of hepatology, 2013-04, Vol.58, p.S88-S88

2013

Volltextzugriff (PDF)

P504 HEMODYNAMIC RESPONSE TO NON-SELECTIVE BETA BLOCKERS DESPITE LACK OF EFFECTS ON HEART RATE AND SYSTEMIC BLOOD PRESSURE

Journal of hepatology, 2014-04, Vol.60 (1), p.S237-S237

2014

Volltextzugriff (PDF)

P0191 : IFN-free regimens overcome the negative effect of portal hypertension on virologic response and viral kinetics in patients with cirrhosis

Journal of hepatology, 2015-04, Vol.62, p.S376-S376

2015

Volltextzugriff (PDF)

1 – 25 von 174

Suche als RSS-Feed

Aktive Filter

SpracheKoreanisch

ThemaLife Sciences & Biomedicine

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(166)
Mit Volltextzugriff
(156)

Publikationsform

Artikel
(174)

Sprache

Englisch
(158)
Deutsch
(16)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Journal Of Hepatology
(82)
Gastrointestinal Endoscopy
(27)
Gastroenterology
(13)
Plos One
(6)
Hepatology
(5)
Alimentary Pharmacology & Therapeutics
(4)
Endoscopy
(4)
Acta Medica Austriaca
(3)
Deutsche Medizinische Wochenschrift
(2)
Klinische Wochenschrift
(2)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Impact of patatin‐like phospholipase domain containing 3 rs738409 G/G genotype on hepatic decompensation and mortality in patients with portal hypertension

Exclusion of Varices Via Transient Elastography Combined with Platelet Count According to the Baveno VI Guidelines can Only be Made for Large not Small Varices

The Albicc Model: A new Prognostic Tool for Prediction of Short-Term Survival in Patients with End-Stage Liver Disease

Bacterial infections in cirrhosis – a retrospective analysis updating on microbiology and resistance rates

P1027 IS THE ELF-SCORE A VALID SUBSTITUTION FOR HVPG TO DETECT CLINICALLY SIGNIFICANT PORTAL HYPERTENSION (CSPH) NON-INVASIVELY?

P524 COMPARISON OF DIFFERENT MODELS IN PREDICTING CLINICALLY SIGNIFICANT PORTAL HYPERTENSION INCLUDING ELF-SCORE AND vWF-Ag

P0130 : VITRO-Score (vWF-Ag/thrombocytes) predicts mortality in patients with liver cirrhosis independent of child-pugh stage and meld score

Liver Stiffness Assessed by Transient Elastography can not Predict the Hemodynamic Response to Non-Selective Betablockers

Von Willebrand factor antigen predicts portal hypertensive bleeding, infections, and survival, independently of portal hypertension severity

The novel point shear-wave elastography method ElastPQ® is accurate for non-invasive evaluation of liver fibrosis and portal hypertension

Preoperative von willebrand factor – antigen predicts clinical outcome after liver resection: a prospective, international, multicenter trial

239 INFLUENCE OF BMI ON THE RESPONSE TO BETA-BLOCKER THERAPY IN PRIMARY AND SECONDARY PROPHYLAXIS OF VARICEAL BLEEDING IN LIVER CIRRHOSIS

P1083 VON WILLEBRAND FACTOR ANTIGEN (vWF-Ag): A NON-INVASIVE PREDICTOR OF TREATMENT RESPONSE AND SEVERE ADVERSE EVENTS IN HCV PATIENTS WITH DAA BASED TRIPLE THERAPY

P0218 : Factors associated with hemodynamic response to propranolol and carvedilol in cirrhotic patients

O019 : The value of different non-invasive tests for predicting the presence of clinically significant portal hypertension and esophageal varices in cirrhotic patients

P0212 : Identifying the trigger matters – outcome of severe acute kidney injury in patients with cirrhosis and ascites

P0208 : Hemodynamic response to non-selective beta-blockers is not influenced by the presence of metabolic syndrome

O050 : A new algorithm for predicting the hepatocellular carcinoma occurrence in cirrhotic patients

Interferon-Free Daa Regimens Decrease Portal Pressure and Halt Histological Necroinflammation in HIV/HCV coinfected Patients

The Evolution of Portal Pressure after Viral Suppression with Interferon-Free Therapies and its Correlation with the Change in Liver Stiffness

621 EVALUATION OF A NEW BALLOON OCCLUSION CATHETER DESIGNED FOR HVPG MEASUREMENT

1410 A RANDOMIZED, CONTROLLED, MULTICENTRE TRIAL COMPARING ENDOSCOPIC BAND LIGATION VERSUS TIPS IN CIRRHOTIC PATIENTS WITH RECURRENT VARICEAL BLEEDING NON-RESPONDING TO PHARMACOLOGICAL THERAPY

202 VON WILLEBRAND FACTOR – A MARKER FOR HEPATOPULMONARY SYNDROME

P504 HEMODYNAMIC RESPONSE TO NON-SELECTIVE BETA BLOCKERS DESPITE LACK OF EFFECTS ON HEART RATE AND SYSTEMIC BLOOD PRESSURE

P0191 : IFN-free regimens overcome the negative effect of portal hypertension on virologic response and viral kinetics in patients with cirrhosis

Aktive Filter

Suchergebnisse filtern